USPTO serial 79294155
Reviewed by CopyMark Law Group
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Surgical apparatus and instruments and medical apparatus and instruments for use in surgery; surgical devices for use in drug delivery, namely syringes, hypodermic needles, catheters and cannulas for use in drug delivery; external and implantable medical devices, namely prosthetic devices in the nature of artificial gastrointestinal implants, diagnostic medical devices for diagnosing gastrointestinal disorders and diseases, and devices to control the fluid in and out of stoma; Medical instruments, devices and apparatus for use in diagnostic testing of the gastrointestinal tract; medical devices for use in treating or diagnosing functional gastrointestinal disorders; gastrointestinal implants composed of artificial materials; medical instruments for delivery and retrieval of gastrointestinal implants; medical apparatus, namely, systems for delivery and retrieval of gastrointestinal implants; surgical devices for use with patients with colorectal cancer and other gastrointestinal diseases; surgical implants comprised of artificial materials; surgical instruments and apparatus; medical instruments for interstitial thermotherapy of biological tissue; prosthetic artificial gastrointestinal implants and implants for use in urostomies; medical implants comprised of artificial materials; intravascular implants made from artificial materials; medical devices for placing and securing catheters; catheters; medical devices for use in treating or diagnosing rectal cancer, colon cancer, polyps, fistulas, high output ileostomies, high output fistulas; medical devices to assist in trans-anal surgery; medical devices for intestinal re-feeding; medical devices for intestinal drug deployment, sold empty; medical devices for use in treating or diagnosing gastrointestinal disease | ACTIVE | — |
| 042 | Providing a platform-as-a-service (PaaS) featuring computer software platforms to enable patients and health care providers to interact remotely, health care providers to access and manage patient medical data, patients to receive information and advertising related to their health care, and patients and clinicians to purchase health care products, for digital health care purposes; and medical research services and scientific laboratory services for acquiring, testing and screening data within the framework of continuous health monitoring | ACTIVE | — |
| 044 | Medical services and surgical services, namely gastrointestinal surgery, gynaecological surgery, colorectal surgery and endoscopies of the gastrointestinal tract; Medical and surgical diagnostic testing, monitoring and reporting services; fitting of prosthetics; medical diagnostic testing, monitoring and reporting services in the fields of medicine related to the gastrointestinal tract; DNA screening for medical purposes, namely, medical DNA and genetic testing for the diagnosis of conditions of the gastrointestinal tract; medical diagnostic testing and reporting services for conditions of the gastrointestinal tract; Collection of human cell or tissue samples for the medical diagnosis of conditions of the gastrointestinal tract; remote patient monitoring services to assist medical professionals in providing medical diagnosis and treatment; medical services, namely, monitoring of losses of intestinal fluid from enterostomies; medical services, namely, monitoring of patient adherence to intestinal re-feeding; medical services, namely, intestinal drug delivery services; medical services, namely, intestinal probiotic delivery services; medical services, namely, intestinal microbiome monitoring | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 5, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 11, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 11, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 11, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 4, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 16, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 16, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 28, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 28, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 19, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 13, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 13, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 30, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 30, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jun 23, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 4, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 31, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 30, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 30, 2021 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Apr 23, 2021 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Apr 23, 2021 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 23, 2021 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 13, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 12, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 12, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 20, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 27, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 27, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 7, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 6, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 29, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 2, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 28, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 24, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |